These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 11896472)

  • 1. Activators of soluble guanylate cyclase for the treatment of male erectile dysfunction.
    Brioni JD; Nakane M; Hsieh GC; Moreland RB; Kolasa T; Sullivan JP
    Int J Impot Res; 2002 Feb; 14(1):8-14. PubMed ID: 11896472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulators and activators of soluble guanylate cyclase for urogenital disorders.
    Mónica FZ; Antunes E
    Nat Rev Urol; 2018 Jan; 15(1):42-54. PubMed ID: 29133940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of soluble guanylate cyclase for the treatment of erectile dysfunction.
    Lasker GF; Pankey EA; Kadowitz PJ
    Physiology (Bethesda); 2013 Jul; 28(4):262-9. PubMed ID: 23817801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nesfatin-1 regulates the phenotype transition of cavernous smooth muscle cells by activating PI3K/AKT/mTOR signaling pathway to improve diabetic erectile dysfunction.
    Chen K; Huang B; Feng J; Hu Z; Fan S; Ren S; Tian H; Abdulkarem M M AM; Wang X; Tuo Y; Liang X; Xie H; He R; Li G
    PLoS One; 2024; 19(9):e0304485. PubMed ID: 39226294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution of small molecule enzyme activators.
    Dow LF; Case AM; Paustian MP; Pinkerton BR; Simeon P; Trippier PC
    RSC Med Chem; 2023 Nov; 14(11):2206-2230. PubMed ID: 37974956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erectile Dysfunction: Treatments, Advances and New Therapeutic Strategies.
    Argiolas A; Argiolas FM; Argiolas G; Melis MR
    Brain Sci; 2023 May; 13(5):. PubMed ID: 37239274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and therapeutic applications of nitric oxide releasing materials to treat erectile dysfunction.
    Davies KP
    Future Sci OA; 2015 Aug; 1(1):. PubMed ID: 27019746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Diagnosis and Management of Erectile Dysfunction.
    Pastuszak AW
    Curr Sex Health Rep; 2014 Sep; 6(3):164-176. PubMed ID: 25878565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of reactive gliosis prevents neovascular growth in the mouse model of oxygen-induced retinopathy.
    DeNiro M; Al-Mohanna FH; Al-Mohanna FA
    PLoS One; 2011; 6(7):e22244. PubMed ID: 21779402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction.
    Lasker GF; Maley JH; Kadowitz PJ
    Adv Pharmacol Sci; 2010; 2010():. PubMed ID: 21152267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future is today: emerging drugs for the treatment of erectile dysfunction.
    Albersen M; Shindel AW; Mwamukonda KB; Lue TF
    Expert Opin Emerg Drugs; 2010 Sep; 15(3):467-80. PubMed ID: 20415601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo studies on the importance of the soluble guanylyl cyclase α1 subunit in penile erection.
    Decaluwé K; Nimmegeers S; Thoonen R; Buys E; Brouckaert P; Van de Voorde J
    World J Urol; 2010 Oct; 28(5):643-50. PubMed ID: 20098992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chuanxiongzine relaxes isolated corpus cavernosum strips and raises intracavernous pressure in rabbits.
    Xiao HJ; Wang T; Chen J; Fan LC; Yin CP; Liu JH; Gao X
    Int J Impot Res; 2010; 22(2):120-6. PubMed ID: 19940852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Looking to the future for erectile dysfunction therapies.
    Hatzimouratidis K; Hatzichristou DG
    Drugs; 2008; 68(2):231-50. PubMed ID: 18197727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of nitric oxide in erectile dysfunction: implications for medical therapy.
    Burnett AL
    J Clin Hypertens (Greenwich); 2006 Dec; 8(12 Suppl 4):53-62. PubMed ID: 17170606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro models: research in physiology and pharmacology of the lower urinary tract.
    Moreland RB
    Br J Pharmacol; 2006 Feb; 147 Suppl 2(Suppl 2):S56-61. PubMed ID: 16465184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of sildenafil citrate (Viagra) on segmental branches of bilateral renal arteries.
    Ardicoglu A; Kocakoc E; Yuzgec V; Bozgeyik Z; Canatan H; Kiris A
    Int Urol Nephrol; 2005; 37(4):785-9. PubMed ID: 16362600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracavernous pharmacotherapy for erectile dysfunction.
    Bella AJ; Brock GB
    Endocrine; 2004; 23(2-3):149-55. PubMed ID: 15146094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats.
    Brioni JD; Moreland RB; Cowart M; Hsieh GC; Stewart AO; Hedlund P; Donnelly-Roberts DL; Nakane M; Lynch JJ; Kolasa T; Polakowski JS; Osinski MA; Marsh K; Andersson KE; Sullivan JP
    Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6758-63. PubMed ID: 15087502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of erectile dysfunction in 2005].
    Porst H
    Urologe A; 2003 Oct; 42(10):1330-6. PubMed ID: 14569381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.